17 results
8-K
EX-10.1
ARVN
Arvinas Inc
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
, the synthesis, manufacturing, processing, formulating, packaging, labeling, holding, quality control testing and release of such Licensed Product … , but not formulations, packaging, labeling, analyzing or testing of such Licensed Product.
1.134 “Manufacturing-Specific Patents” means all Collaboration
8-K
EX-1.1
c6suhlo365eretpzo6lf
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
8-K
EX-1.1
uq2o bq7fgo65f3j
12 Nov 19
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
4:02pm
10-K
6cjzy09yf7uui6
26 Mar 19
Annual report
4:31pm
DRS/A
7v9joxnyydw5trv
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
EX-10.6
kkt30we2 3cg
22 Jun 18
Draft registration statement
12:00am
DRS
poqu6 iuuu
22 Jun 18
Draft registration statement
12:00am
DRS
EX-10.7
rpywj2r4f0z9j 9a940
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next